Cann Group Limited announced that Mr. John Sharman has been appointed to the Board of Directors, with the appointment taking effect April 27, 2021. Mr. Sharman's appointment will be confirmed by shareholders at the Company's AGM scheduled for November 2021. Mr. Sharman has extensive international business experience as a Managing Director, CEO, CFO and non-executive director with public and private companies, including several ASX listed entities. Mr. Sharman is currently the CEO of Universal Biosensors Inc. Prior to that he served 10 years as CEO of Medical Developments International.